Profile: NoAb BioDiscoveries Inc. specializes in in vivo pharmacokinetics studies, in vitro ADME assays and gene expression assays, offering the customers the ability to profile compounds for selection of the best candidates for further pre-clinical & clinical development. Our DTEx™ is a microarray-based technology, which allows investigators the ability to survey the effects of drug treatment on the expression level of genes involved in ADME pathways. We also offer cell permeability assays, plasma protein binding, cytochrome P450 enzyme subtype inhibition studies, metabolic stability in hepatocytes, metabolic stability in liver subcellular fractions, plasma stability assays and cytotoxicity assays.